Navigation Links
ResMed Inc. to Present at Upcoming Conferences in June
Date:5/27/2009

SAN DIEGO, May 27 /PRNewswire-FirstCall/ -- ResMed Inc. (NYSE: RMD) announced today that it will be presenting at three upcoming conferences. David Pendarvis, SVP Organization Development and General Counsel will present at the William Blair Growth Stock Conference at the Four Seasons in Chicago on June 10, 2009 at 9:20 a.m. US Central Time. Kieran Gallahue, President and CEO will present at the Jefferies Third Annual Healthcare Conference at the Mandarin Oriental in New York City on June 18, 2009 at 9:30 a.m. US Eastern Time. David Pendarvis, SVP Organization Development and General Counsel will present at the Wachovia/Wells Fargo Annual Mid-Year Equity Conference at the Intercontinental Boston Hotel in Boston on June 23, 2009 at 4:00 p.m. US Eastern Time.

The Company's presentations will be webcast. To access the live webcast or the archived webcast of the presentation, please log onto the Company's website at http://investor.resmed.com. Further information can be obtained by contacting Constance Bienfait at ResMed Inc., San Diego, at +1(858) 836-5971 or by visiting the Company's multilingual Web site at www.resmed.com.

ResMed is a leading developer, manufacturer, and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. We are dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing.


'/>"/>
SOURCE ResMed Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. ResMed Inc. to Present at Upcoming Healthcare Conferences in May
2. ResMed Announces Conference Call and Webcast to Discuss Third Quarter 2009 Results
3. ResMed Inc Announces Record Financial Results for the Quarter and Six Months Ended December 31, 2008
4. ResMed to Webcast Second Quarter 2009 Earnings Conference Call
5. ResMed Inc Announces Record Financial Results for the Quarter Ended September 30, 2008
6. ResMed to Webcast First Quarter 2009 Earnings Conference Call
7. ResMed to Webcast Third Quarter 2008 Earnings Conference Call
8. RESMED to Webcast Second Quarter 2008 Earnings Conference Call
9. ResMed to Webcast First Quarter 2008 Earnings Conference Call
10. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
11. Ceregene Presents Additional Clinical Data from Phase 2 Trial of CERE-120 for Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... is proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon ... beautiful women in the world, and the most handsome men, look naturally attractive. ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners ... extensive sequencing and genomics experience, as Vice President of North American Capital Sales at ... responsible for leading the sales team in the commercialization of the HTG EdgeSeq system ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: